Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. (Q46307704)

21 December 2017

title

Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. (English)

1 reference

21 December 2017

0 references

1 reference

Gunnar Aasen

1

1 reference

21 December 2017

Hans Fagertun

series ordinal

2

1 reference

21 December 2017

Serena Tonstad

series ordinal

3

1 reference

21 December 2017

Johan Halse

series ordinal

4

1 reference

21 December 2017

publication date

1 January 2009

1 reference

21 December 2017

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

21 December 2017

volume

69

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

181-189

1 reference

21 December 2017

Relationships of generalized and regional adiposity to insulin sensitivity in men.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Metabolic implications of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Contributions of total and regional fat mass to risk for cardiovascular disease in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Lower-body adiposity and metabolic protection in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Favourable association of leg fat with cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenesity in Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Body composition analysis by dual X-ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Sex steroid hormones, upper body obesity, and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Lower-body fat mass as an independent marker of insulin sensitivity--the role of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802464641

10.1080/00365510802464641

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18937100

1 reference

21 December 2017